Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2007World Journal of Gastroenterology

Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up

View Full Paper
Ask AI
Bookmark
Share

Authors

RCRenato CavigliaUniversity of Parma

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Renato Caviglia (2007) studied this question.

synapsesocial.com/papers/6a0ea18aa14f152feaf9a130https://doi.org/10.3748/wjg.v13.i39.5238
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The incidence and management of infusion reactions to infliximab: a large center experience2003 · 43 citations
  2. 2Review article: infliximab therapy for inflammatory bowel disease – seven years on2006 · 229 citations
  3. 3Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis2006 · 187 citations
  4. 4Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease1999 · 2,766 citations
  5. 5Remission in Patients with Crohn's Disease is Associated with Improvement in Employment and Quality of Life and a Decrease in Hospitalizations and Surgeries2004 · 265 citations